Silicon Valley Capital Partners Bristol Myers Squibb CO Transaction History
Silicon Valley Capital Partners
- $894 Million
- Q4 2024
A detailed history of Silicon Valley Capital Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Silicon Valley Capital Partners holds 706 shares of BMY stock, worth $35,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
706Holding current value
$35,342% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,788Shares Held
1.57BCall Options Held
27.4MPut Options Held
27.8M-
Vanguard Group Inc Valley Forge, PA191MShares$9.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.94 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.81 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.76 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$3.03 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...